Iradimed Co Stock Price History
| IRMD Stock | USD 60.71 0.31 0.51% |
Below is the normalized historical share price chart for Iradimed Co extending back to July 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iradimed stands at 60.71, as last reported on the 26th of June, with the highest price reaching 60.94 and the lowest price hitting 59.60 during the day.
If you're considering investing in Iradimed Stock, it is important to understand the factors that can impact its price. Iradimed appears to be very steady, given 3 months investment horizon. Iradimed holds Efficiency (Sharpe) Ratio of 0.1, which attests that the entity had a 0.1 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Iradimed, which you can use to evaluate the volatility of the firm. Please utilize Iradimed's Downside Deviation of 1.81, market risk adjusted performance of 0.2852, and Risk Adjusted Performance of 0.1716 to validate if our risk estimates are consistent with your expectations. At present, Iradimed's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.04, whereas Common Stock Total Equity is forecasted to decline to 1,175. . At present, Iradimed's Price Book Value Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 3.23, whereas Price Earnings Ratio is forecasted to decline to 34.42. Iradimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of July 2014 | 200 Day MA 53.8745 | 50 Day MA 55.1246 | Beta 0.932 |
Sharpe Ratio = 0.1003
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.52 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.25 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Iradimed is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iradimed by adding it to a well-diversified portfolio.
Price Book 8.5281 | Enterprise Value Ebitda 30.628 | Price Sales 10.2188 | Shares Float 7.2 M | Dividend Share 0.64 |
Iradimed Stock Price History Chart
There are several ways to analyze Iradimed Stock price data. The simplest method is using a basic Iradimed candlestick price chart, which shows Iradimed price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 9, 2025 | 60.8 |
| Lowest Price | April 8, 2025 | 48.52 |
Iradimed June 26, 2025 Stock Price Synopsis
Various analyses of Iradimed's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Iradimed Stock. It can be used to describe the percentage change in the price of Iradimed from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Iradimed Stock.| Iradimed Price Action Indicator | 0.60 | |
| Iradimed Accumulation Distribution | 1,408 | |
| Iradimed Price Daily Balance Of Power | 0.23 | |
| Iradimed Price Rate Of Daily Change | 1.01 |
Iradimed June 26, 2025 Stock Price Analysis
Iradimed Stock Price History Data
The price series of Iradimed for the period between Fri, Mar 28, 2025 and Thu, Jun 26, 2025 has a statistical range of 12.28 with a coefficient of variation of 6.39. Under current investment horizon, the daily prices are spread out with arithmetic mean of 54.23. The median price for the last 90 days is 52.86. The company completed dividends distribution on 2025-05-20.| Open | High | Low | Close | Volume | ||
06/26/2025 | 60.64 | 60.94 | 59.60 | 60.71 | 64,019 | |
06/25/2025 | 60.74 | 60.74 | 59.60 | 60.40 | 54,387 | |
06/24/2025 | 59.51 | 60.64 | 58.94 | 60.48 | 56,128 | |
| 06/23/2025 | 57.95 | 59.58 | 57.74 | 59.50 | 81,114 | |
| 06/20/2025 | 59.05 | 59.05 | 57.50 | 58.24 | 106,375 | |
| 06/18/2025 | 58.02 | 59.01 | 57.64 | 58.45 | 100,510 | |
06/17/2025 | 57.98 | 59.91 | 57.82 | 57.98 | 40,859 | |
06/16/2025 | 58.60 | 58.85 | 57.80 | 58.52 | 42,604 | |
06/13/2025 | 58.93 | 60.36 | 57.66 | 58.17 | 39,461 | |
06/12/2025 | 59.69 | 59.94 | 58.98 | 59.56 | 29,855 | |
06/11/2025 | 59.93 | 60.47 | 59.30 | 60.01 | 44,335 | |
06/10/2025 | 61.04 | 61.04 | 59.58 | 59.95 | 40,607 | |
06/09/2025 | 61.00 | 61.05 | 59.84 | 60.80 | 36,303 | |
06/06/2025 | 61.15 | 61.32 | 59.97 | 60.50 | 29,705 | |
06/05/2025 | 60.67 | 61.22 | 60.09 | 60.36 | 58,418 | |
06/04/2025 | 60.07 | 61.62 | 59.80 | 60.78 | 48,537 | |
06/03/2025 | 58.04 | 60.14 | 56.77 | 59.79 | 51,625 | |
06/02/2025 | 57.38 | 58.27 | 55.50 | 57.79 | 76,983 | |
05/30/2025 | 57.62 | 58.35 | 57.15 | 57.88 | 59,181 | |
| 05/29/2025 | 53.89 | 59.05 | 53.41 | 58.14 | 98,593 | |
05/28/2025 | 52.45 | 52.94 | 51.34 | 51.66 | 27,126 | |
05/27/2025 | 51.53 | 52.69 | 51.26 | 52.55 | 24,902 | |
05/23/2025 | 51.71 | 51.89 | 50.88 | 51.09 | 27,862 | |
05/22/2025 | 52.76 | 53.53 | 52.14 | 52.28 | 20,816 | |
05/21/2025 | 53.01 | 54.79 | 52.50 | 53.21 | 30,874 | |
05/20/2025 | 54.00 | 54.64 | 51.55 | 53.29 | 21,437 | |
05/19/2025 | 52.85 | 54.35 | 52.82 | 54.04 | 24,481 | |
05/16/2025 | 53.53 | 54.47 | 53.06 | 53.74 | 49,113 | |
05/15/2025 | 51.96 | 53.69 | 51.96 | 53.69 | 21,831 | |
05/14/2025 | 52.73 | 52.73 | 51.47 | 51.75 | 34,943 | |
05/13/2025 | 52.71 | 53.23 | 52.61 | 53.06 | 22,629 | |
05/12/2025 | 53.22 | 53.32 | 52.34 | 52.41 | 25,146 | |
| 05/09/2025 | 52.35 | 52.91 | 51.53 | 51.70 | 24,445 | |
05/08/2025 | 51.36 | 52.57 | 51.08 | 52.50 | 42,769 | |
05/07/2025 | 51.27 | 51.66 | 50.45 | 50.85 | 37,464 | |
| 05/06/2025 | 51.56 | 51.58 | 50.15 | 50.86 | 34,199 | |
| 05/05/2025 | 53.71 | 53.71 | 51.61 | 52.14 | 37,965 | |
05/02/2025 | 53.20 | 53.36 | 52.57 | 53.30 | 27,389 | |
05/01/2025 | 52.39 | 53.51 | 50.64 | 52.77 | 35,640 | |
04/30/2025 | 52.95 | 53.30 | 51.80 | 52.25 | 37,757 | |
04/29/2025 | 52.88 | 53.97 | 52.83 | 53.53 | 20,064 | |
04/28/2025 | 53.10 | 53.92 | 52.42 | 52.85 | 24,675 | |
04/25/2025 | 52.64 | 53.47 | 50.46 | 53.15 | 28,235 | |
04/24/2025 | 49.84 | 53.44 | 49.84 | 52.96 | 34,431 | |
04/23/2025 | 52.61 | 53.68 | 51.94 | 52.56 | 37,254 | |
04/22/2025 | 50.97 | 52.50 | 50.49 | 51.93 | 33,539 | |
04/21/2025 | 51.04 | 51.94 | 49.98 | 50.62 | 34,963 | |
04/17/2025 | 51.65 | 52.28 | 50.96 | 51.61 | 32,073 | |
04/16/2025 | 51.79 | 51.94 | 50.47 | 51.80 | 27,577 | |
04/15/2025 | 52.30 | 52.79 | 51.09 | 51.80 | 31,841 | |
04/14/2025 | 52.85 | 52.89 | 49.96 | 52.86 | 47,182 | |
04/11/2025 | 50.34 | 52.37 | 49.13 | 52.13 | 57,725 | |
04/10/2025 | 50.94 | 50.94 | 48.83 | 49.94 | 24,558 | |
| 04/09/2025 | 48.05 | 52.84 | 47.33 | 51.60 | 55,588 | |
04/08/2025 | 50.04 | 50.46 | 47.84 | 48.52 | 44,097 | |
| 04/07/2025 | 48.23 | 51.59 | 47.70 | 49.22 | 50,716 | |
04/04/2025 | 50.00 | 50.00 | 48.40 | 49.76 | 43,214 | |
04/03/2025 | 51.87 | 52.70 | 50.65 | 51.20 | 25,904 | |
04/02/2025 | 52.68 | 53.43 | 52.49 | 53.43 | 22,775 | |
04/01/2025 | 52.32 | 53.93 | 52.00 | 53.28 | 27,582 | |
03/31/2025 | 51.67 | 52.54 | 51.00 | 52.32 | 56,011 |
About Iradimed Stock history
Iradimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iradimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iradimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iradimed stock prices may prove useful in developing a viable investing in Iradimed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.8 M | 13.1 M | |
| Net Income Applicable To Common Shares | 14.8 M | 15.5 M |
Iradimed Quarterly Net Working Capital |
|
Iradimed Stock Technical Analysis
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Iradimed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iradimed's price direction in advance. Along with the technical and fundamental analysis of Iradimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iradimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1716 | |||
| Jensen Alpha | 0.2069 | |||
| Total Risk Alpha | 0.183 | |||
| Sortino Ratio | 0.1118 | |||
| Treynor Ratio | 0.2752 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |